Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of OATP1B1 Genotype on the Pharmacokinetics,Lipid Lowering Effect, and Lipid Profiles After Rosuvastatin Administration

NCT01218347 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01218347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of OATP1B1 Genotype on the Pharmacokinetics,Lipid Lowering Effect, and Lipid Profiles After Rosuvastatin Administration
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2010
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

organic anion transporting polypeptide1b1 (oatp1b1), rosuvastatin